The 3rd Conference on Asian Trends in Prostate Cancer Hormone Therapy.

Hideyuki Akaza, Seiji Naito, Shu Jen Chang, Kuang Kuo Chen, Christopher Cheng, Han Yong Choi, Tomoaki Fujioka, Shiro Hinotsu, Yoshihiko Hirao, Sung Joon Hong, Choung Soo Kim, Wun Jae Kim, Sang Eun Lee, Masaru Murai, Osamu Ogawa, Joung Sik Rim, Doddy M. Soebadi, Jae Mann Song, Taiji Tsukamoto, Rainy UmbasMichiyuki Usami, Shujie Xia, Chi Rei Yang, Jin Han Yoon, Liqun Zhou

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

From its inception in 2001, the Conference on Asian Trends in Prostate Cancer Hormone Therapy has served as an annual forum for Asian urologists to compare data on prostate cancer and to discuss issues regarding the use of hormone therapy. The 3rd conference, held in Tokyo in December 2003, began with participants from China, Indonesia, Japan, Korea, Singapore, and Taiwan presenting QOL data deriving from a survey of patients with prostate cancer. For this purpose, each country translated the Functional Assessment of Cancer Therapy-Prostate (FACT-P) questionnaire into its own language. Although the surveys conducted in each country included a heterogeneous cohort of patients and gave very mixed results, the trial of FACT-P in Asian countries seemed propitious and in future may provide insights that could prove beneficial to patients. Day 2 of the conference included 2 discussions, focusing on the most appropriate number of biopsy cores and the implementation of prospective trials involving the collaboration of Asian countries, respectively. In the latter discussion, although a varied assortment of proposals were put forth, the participants generally agreed that any collaborative study must be a prospective outcome study conducted in a relatively short time not exceeding 2-3 years, and that patient registration should be done using the Internet.

Original languageEnglish
Pages (from-to)1285-1295
Number of pages11
JournalGan to kagaku ryoho. Cancer & chemotherapy
Volume31
Issue number8
Publication statusPublished - Aug 2004
Externally publishedYes

Fingerprint

Prostatic Neoplasms
Hormones
Therapeutics
Indonesia
Tokyo
Singapore
Korea
Taiwan
Internet
China
Japan
Language
Outcome Assessment (Health Care)
Prospective Studies
Biopsy
Surveys and Questionnaires

ASJC Scopus subject areas

  • Cancer Research
  • Pharmacology

Cite this

Akaza, H., Naito, S., Chang, S. J., Chen, K. K., Cheng, C., Choi, H. Y., ... Zhou, L. (2004). The 3rd Conference on Asian Trends in Prostate Cancer Hormone Therapy. Gan to kagaku ryoho. Cancer & chemotherapy, 31(8), 1285-1295.

The 3rd Conference on Asian Trends in Prostate Cancer Hormone Therapy. / Akaza, Hideyuki; Naito, Seiji; Chang, Shu Jen; Chen, Kuang Kuo; Cheng, Christopher; Choi, Han Yong; Fujioka, Tomoaki; Hinotsu, Shiro; Hirao, Yoshihiko; Hong, Sung Joon; Kim, Choung Soo; Kim, Wun Jae; Lee, Sang Eun; Murai, Masaru; Ogawa, Osamu; Rim, Joung Sik; Soebadi, Doddy M.; Song, Jae Mann; Tsukamoto, Taiji; Umbas, Rainy; Usami, Michiyuki; Xia, Shujie; Yang, Chi Rei; Yoon, Jin Han; Zhou, Liqun.

In: Gan to kagaku ryoho. Cancer & chemotherapy, Vol. 31, No. 8, 08.2004, p. 1285-1295.

Research output: Contribution to journalArticle

Akaza, H, Naito, S, Chang, SJ, Chen, KK, Cheng, C, Choi, HY, Fujioka, T, Hinotsu, S, Hirao, Y, Hong, SJ, Kim, CS, Kim, WJ, Lee, SE, Murai, M, Ogawa, O, Rim, JS, Soebadi, DM, Song, JM, Tsukamoto, T, Umbas, R, Usami, M, Xia, S, Yang, CR, Yoon, JH & Zhou, L 2004, 'The 3rd Conference on Asian Trends in Prostate Cancer Hormone Therapy.', Gan to kagaku ryoho. Cancer & chemotherapy, vol. 31, no. 8, pp. 1285-1295.
Akaza H, Naito S, Chang SJ, Chen KK, Cheng C, Choi HY et al. The 3rd Conference on Asian Trends in Prostate Cancer Hormone Therapy. Gan to kagaku ryoho. Cancer & chemotherapy. 2004 Aug;31(8):1285-1295.
Akaza, Hideyuki ; Naito, Seiji ; Chang, Shu Jen ; Chen, Kuang Kuo ; Cheng, Christopher ; Choi, Han Yong ; Fujioka, Tomoaki ; Hinotsu, Shiro ; Hirao, Yoshihiko ; Hong, Sung Joon ; Kim, Choung Soo ; Kim, Wun Jae ; Lee, Sang Eun ; Murai, Masaru ; Ogawa, Osamu ; Rim, Joung Sik ; Soebadi, Doddy M. ; Song, Jae Mann ; Tsukamoto, Taiji ; Umbas, Rainy ; Usami, Michiyuki ; Xia, Shujie ; Yang, Chi Rei ; Yoon, Jin Han ; Zhou, Liqun. / The 3rd Conference on Asian Trends in Prostate Cancer Hormone Therapy. In: Gan to kagaku ryoho. Cancer & chemotherapy. 2004 ; Vol. 31, No. 8. pp. 1285-1295.
@article{ebc710c31906499f8c92e76c3d453fa4,
title = "The 3rd Conference on Asian Trends in Prostate Cancer Hormone Therapy.",
abstract = "From its inception in 2001, the Conference on Asian Trends in Prostate Cancer Hormone Therapy has served as an annual forum for Asian urologists to compare data on prostate cancer and to discuss issues regarding the use of hormone therapy. The 3rd conference, held in Tokyo in December 2003, began with participants from China, Indonesia, Japan, Korea, Singapore, and Taiwan presenting QOL data deriving from a survey of patients with prostate cancer. For this purpose, each country translated the Functional Assessment of Cancer Therapy-Prostate (FACT-P) questionnaire into its own language. Although the surveys conducted in each country included a heterogeneous cohort of patients and gave very mixed results, the trial of FACT-P in Asian countries seemed propitious and in future may provide insights that could prove beneficial to patients. Day 2 of the conference included 2 discussions, focusing on the most appropriate number of biopsy cores and the implementation of prospective trials involving the collaboration of Asian countries, respectively. In the latter discussion, although a varied assortment of proposals were put forth, the participants generally agreed that any collaborative study must be a prospective outcome study conducted in a relatively short time not exceeding 2-3 years, and that patient registration should be done using the Internet.",
author = "Hideyuki Akaza and Seiji Naito and Chang, {Shu Jen} and Chen, {Kuang Kuo} and Christopher Cheng and Choi, {Han Yong} and Tomoaki Fujioka and Shiro Hinotsu and Yoshihiko Hirao and Hong, {Sung Joon} and Kim, {Choung Soo} and Kim, {Wun Jae} and Lee, {Sang Eun} and Masaru Murai and Osamu Ogawa and Rim, {Joung Sik} and Soebadi, {Doddy M.} and Song, {Jae Mann} and Taiji Tsukamoto and Rainy Umbas and Michiyuki Usami and Shujie Xia and Yang, {Chi Rei} and Yoon, {Jin Han} and Liqun Zhou",
year = "2004",
month = "8",
language = "English",
volume = "31",
pages = "1285--1295",
journal = "Japanese Journal of Cancer and Chemotherapy",
issn = "0385-0684",
publisher = "Japanese Journal of Cancer and Chemotherapy Publishers Inc.",
number = "8",

}

TY - JOUR

T1 - The 3rd Conference on Asian Trends in Prostate Cancer Hormone Therapy.

AU - Akaza, Hideyuki

AU - Naito, Seiji

AU - Chang, Shu Jen

AU - Chen, Kuang Kuo

AU - Cheng, Christopher

AU - Choi, Han Yong

AU - Fujioka, Tomoaki

AU - Hinotsu, Shiro

AU - Hirao, Yoshihiko

AU - Hong, Sung Joon

AU - Kim, Choung Soo

AU - Kim, Wun Jae

AU - Lee, Sang Eun

AU - Murai, Masaru

AU - Ogawa, Osamu

AU - Rim, Joung Sik

AU - Soebadi, Doddy M.

AU - Song, Jae Mann

AU - Tsukamoto, Taiji

AU - Umbas, Rainy

AU - Usami, Michiyuki

AU - Xia, Shujie

AU - Yang, Chi Rei

AU - Yoon, Jin Han

AU - Zhou, Liqun

PY - 2004/8

Y1 - 2004/8

N2 - From its inception in 2001, the Conference on Asian Trends in Prostate Cancer Hormone Therapy has served as an annual forum for Asian urologists to compare data on prostate cancer and to discuss issues regarding the use of hormone therapy. The 3rd conference, held in Tokyo in December 2003, began with participants from China, Indonesia, Japan, Korea, Singapore, and Taiwan presenting QOL data deriving from a survey of patients with prostate cancer. For this purpose, each country translated the Functional Assessment of Cancer Therapy-Prostate (FACT-P) questionnaire into its own language. Although the surveys conducted in each country included a heterogeneous cohort of patients and gave very mixed results, the trial of FACT-P in Asian countries seemed propitious and in future may provide insights that could prove beneficial to patients. Day 2 of the conference included 2 discussions, focusing on the most appropriate number of biopsy cores and the implementation of prospective trials involving the collaboration of Asian countries, respectively. In the latter discussion, although a varied assortment of proposals were put forth, the participants generally agreed that any collaborative study must be a prospective outcome study conducted in a relatively short time not exceeding 2-3 years, and that patient registration should be done using the Internet.

AB - From its inception in 2001, the Conference on Asian Trends in Prostate Cancer Hormone Therapy has served as an annual forum for Asian urologists to compare data on prostate cancer and to discuss issues regarding the use of hormone therapy. The 3rd conference, held in Tokyo in December 2003, began with participants from China, Indonesia, Japan, Korea, Singapore, and Taiwan presenting QOL data deriving from a survey of patients with prostate cancer. For this purpose, each country translated the Functional Assessment of Cancer Therapy-Prostate (FACT-P) questionnaire into its own language. Although the surveys conducted in each country included a heterogeneous cohort of patients and gave very mixed results, the trial of FACT-P in Asian countries seemed propitious and in future may provide insights that could prove beneficial to patients. Day 2 of the conference included 2 discussions, focusing on the most appropriate number of biopsy cores and the implementation of prospective trials involving the collaboration of Asian countries, respectively. In the latter discussion, although a varied assortment of proposals were put forth, the participants generally agreed that any collaborative study must be a prospective outcome study conducted in a relatively short time not exceeding 2-3 years, and that patient registration should be done using the Internet.

UR - http://www.scopus.com/inward/record.url?scp=4344571163&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4344571163&partnerID=8YFLogxK

M3 - Article

C2 - 15332559

AN - SCOPUS:4344571163

VL - 31

SP - 1285

EP - 1295

JO - Japanese Journal of Cancer and Chemotherapy

JF - Japanese Journal of Cancer and Chemotherapy

SN - 0385-0684

IS - 8

ER -